Thomas H. Kean, Representative
sell disclosed on 22 May 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
Thomas H. Kean, Representative
sell disclosed on 22 May 2026 via House STOCK Act disclosures
Thomas H. Kean, Representative
sell disclosed on 13 Apr 2026 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 18 Mar 2026 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 15 May 2025 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 15 May 2025 via House STOCK Act disclosures
Byron Donalds, Representative
sell disclosed on 14 Apr 2025 via House STOCK Act disclosures
Byron Donalds, Representative
sell disclosed on 14 Apr 2025 via House STOCK Act disclosures
Byron Donalds, Representative
buy disclosed on 10 Feb 2025 via House STOCK Act disclosures
Byron Donalds, Representative
buy disclosed on 10 Feb 2025 via House STOCK Act disclosures
Byron Donalds, Representative
buy disclosed on 10 Feb 2025 via House STOCK Act disclosures
Daniel Goldman, Representative
buy disclosed on 19 May 2023 via House STOCK Act disclosures